Apeloa Pharmaceutical Co.,Ltd (SHE:000739)
China flag China · Delayed Price · Currency is CNY
20.73
-0.14 (-0.67%)
Aug 26, 2026, 3:04 PM CST

SHE:000739 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
9,1019,72811,95711,44010,5068,910
Other Revenue
61.755.4865.3533.9239.132.44
9,1629,78412,02211,47410,5458,943
Revenue Growth
-16.99%-18.62%4.77%8.81%17.92%13.49%
Cost of Revenue
6,6487,2989,2258,6218,0756,579
Gross Profit
2,5152,4862,7962,8532,4702,364
Selling, General & Admin
930.27971.421,1211,125985.33906.43
Research & Development
565.78611.17641.47624.87532.92446.22
Other Operating Expenses
73.0835.3812.7623.331.7633.05
Operating Expenses
1,5901,6081,7851,7751,5631,405
Operating Income
924.29877.831,0121,078906.8959.39
Interest Expense
-29.71-24.65-32.2-43.77-59.23-35.72
Interest & Investment Income
97.53131.7892.17113.4775.83165.7
Currency Exchange Gain (Loss)
-97.17-25.5158.3838.1393.42-23.09
Other Non Operating Income (Expenses)
-1.87-1.822.18-23.85-5.38-3.58
EBT Excluding Unusual Items
893.07957.621,1321,1621,0111,063
Gain (Loss) on Sale of Investments
7.68--10.13-21.7-82.61-23.62
Gain (Loss) on Sale of Assets
8.019.030.281.331.370.28
Asset Writedown
-3.42-5-8.37--4.67-7.95
Other Unusual Items
123.89104.5589.2263.2386.5282.67
Pretax Income
1,0291,0661,2031,2051,0121,114
Income Tax Expense
179.06175.52172.44149.3422.89158.53
Earnings From Continuing Operations
850.17890.681,0311,055989.17955.55
Minority Interest in Earnings
-0.17-00.270.030-
Net Income
850.01890.681,0311,055989.17955.55
Net Income to Common
850.01890.681,0311,055989.17955.55
Net Income Growth
-12.31%-13.62%-2.30%6.69%3.52%17.00%
Shares Outstanding (Basic)
1,1531,1531,1631,1691,1741,179
Shares Outstanding (Diluted)
1,1531,1531,1631,1691,1741,179
Shares Change
-0.50%-0.86%-0.52%-0.40%-0.38%-0.00%
EPS (Basic)
0.740.770.890.900.840.81
EPS (Diluted)
0.740.770.890.900.840.81
EPS Growth
-11.87%-12.87%-1.78%7.12%3.91%17.00%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
437.83833.99748.01400.9817-90.18
Free Cash Flow Per Share
0.380.720.640.340.70-0.08
Dividend Per Share
0.3770.5860.3560.3170.2970.285
Dividend Growth
-46.48%64.68%12.35%6.70%4.21%17.28%
Gross Margin
27.45%25.41%23.26%24.86%23.42%26.43%
Operating Margin
10.09%8.97%8.42%9.39%8.60%10.73%
Profit Margin
9.28%9.10%8.58%9.20%9.38%10.69%
Free Cash Flow Margin
4.78%8.52%6.22%3.49%7.75%-1.01%
EBITDA
1,5981,5401,5761,6311,2961,318
EBITDA Margin
17.44%15.74%13.11%14.21%12.29%14.74%
D&A For EBITDA
673.91662.17564.15553.06389.43358.64
EBIT
924.29877.831,0121,078906.8959.39
EBIT Margin
10.09%8.97%8.42%9.39%8.60%10.73%
Effective Tax Rate
17.40%16.46%14.33%12.40%2.26%14.23%
Revenue as Reported
9,1629,78412,02211,47410,5458,943
Advertising Expenses
-9.3511.299.671.611.86